New Psychoactive Substances in Portugal

Slides:



Advertisements
Similar presentations
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Advertisements

Online Sales and Use of Synthetic Cannabinoids Preliminary findings from a Norwegian study Ola Røed Bilgrei Anne Line Bretteville-Jensen SIRUS.
Building on The “Tough on Drugs Campaign” –By Lauren Lucas.
JUST SAY KNOW: FACTS ABOUT PSYCHOACTIVE DRUGS Rick Csiernik, King’s University College at Western University
Sex, drugs and alcohol – impact on health services Dr Marion Lyons Josie Smith NPHS.
Factors associated with fatal overdoses in Oslo Linn Gjersing, Thomas Clausen, Jørgen Bramness, Helge Waal, Stian Biong & Edle Ravndal.
P ROBLEMS WITH N EW P SYCHOACTIVE S UBSTANCES AND HOW TO DEAL WITH IT Roman Gabrhelík Serbia, 2013.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Annual report 2009: the state of the drugs problem in Europe NB Embargo 5 November :00 CET (Brussels time)
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
A look into the Expert Panels Review By Leigh
A Brief Insight By Leigh Westmore. New Psychoactive Substances Legal Highs Designer Drugs (70’s) Synthetic drugs “mimic known drugs” Possible long term.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
Chapter 26- Illegal Drugs
Graphic Overview Treaty Framework International Organizational Structure Domestic Constituencies States Party.
© Marvin Krank, Kelowna BC, 2004 November 8, 2004 Youth at risk What they are doing What is happening to them Why ? What we can do about it Marvin Krank.
Current Trends: NPS and Young People in Midlothian.
Youth In Focus!! Maria Peglitsi Cyprus Anti Drug Council July 2009.
Gregor Burkhart - EMCDDA / OEDT - 1 … how to deal with Risks - drugs - Gregor Burkhart, EMCDDA, July 2009 CONFERENCE ON THE HEALTH OF YOUNG PEOPLE: BE.
NPS Symposium Charles Berry House Tuesday November 3 rd 2015 Dr Rob Hampton
European Commission EU Action to reduce alcohol related harm: recent developments and next steps Ceri Thompson Team Leader: Alcohol and Drugs DG Health.
TEDI TEDI Trans European Drug Information Mireia Ventura – Energy control Barcelona Alexander Bücheli – City of Zurich youth counseling Streetwork.
New Psychoactive Substances Presented by Barry James Forensic Scientist (Drugs) 15 th September 2015.
NEW PSYCHOACTIVE SUBSTANCES ROMANIA’s Experience Lavinius Sava– sociologist NAA/ Romania’sFocal Point Budapest,
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
Annual report 2012: the state of the drugs problem in Europe Name, date.
Samantha Arcand, BSW, LAC-E Western Montana Addiction Services Project SUCCESS Counselor Big Sky High School (406) ext Room 15C Monday 9:00.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
New Psychoactive Substances: an overview of the evidence Isla Wallace, Social Researcher Drugs Research Team
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
The challenge of new party drugs –
NEW PSYCHOACTIVE SUBSTANCES (NPS) AND HARM REDUCTION
Legal and Illegal Drugs
ESPAD Report 2015 Results from the European School Survey Project on Alcohol and Other Drugs ESPAD Group Lisbon, 20 September 2016.
Course of Alcohol Use Disorders: Data from a 35 Year Follow Up
The effectiveness and cost-effectiveness of alcohol control policies PHE Evidence Review 31st January 2017.
MIREIA VENTURA VILAMALA, PhD
DR. Fernando Caudevilla Energy control (ABD)
Alcohol, a tricky liquid
The determinants of health and individual human development of Australian’s children Chapter 7.
Lung cancer prevalence on the rise (Nov. 2014)
NPN Workshop Overview and Implications for Prevention
THE GERMAN NEW PSYCHOACTIVE SUBSTANCE LAW (NPSG): PERCEIVED AND EXPECTED OUTCOMES IN THE FIRST STAGE OF IMPLEMENTATION. Tessa-Virginia Hannemann.
There were however very few of you that used ALL the info I provided!
Professor Paul I Dargan
The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe Rachel Christie, PhD 24 October 2017, Lisbon Lisbon Addictions.
Monitoring drug-related crime in Europe: state of play
World Drug Report 2018.
The social epidemiology of alcohol and drug use among Israeli school-aged children: Recent developments and current challenges Prof. Yossi Harel-Fisch.
Decriminalisation Policy and the role of the CDT
New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM):
Results of an international drug testing service for cryptomarket users Mireia Ventura· ABD – Energy Control 15th May 2017.
Social Awareness Programme
Statewide Epidemiological Outcomes Workgroup (SEOW) Prioritization of Priority Substances December, 2017.
To use or not to use? An exploration of cannabis use motives and constraints Dr Liz Temple
Current Trends: NPS and Young People in Midlothian
A Spanish Drug Checking service for recreational drug users
Drug trends: The Vermont perspective
Chapter 5 Promoting youth health and wellbeing
Designer drugs of abuse: The science behind the headlines
Drugs the law & government responses
Substance Use as a Continuum
What is the definition of drug?
(include your name, your business name/logo/image of your product)
ADDICTION
Skopje, 21 November 2017, General Population Survey results– launch
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
TEDI project (Trans European Drug Information)
Presentation transcript:

New Psychoactive Substances in Portugal Trends and approaches Joana Silva Susana Henriques

NPS - new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat comparable to that posed by substances listed in these conventions' Sold in smartshops, growshops or on-line, between February 2007 and April 2013 – legislation changes (decree-law Nº 54/2013 of 17th April) According to recent reports from EU Early Warning System both variety and quantity of NPS on Europe’s market still increasing. In 2015 were identified 98 new psychoactive substances in the market such as synthetic cannabinoids, stimulants, hallucinogens and opioids (EMCDDA, 2016). The growth in the market is also responsible for the increase in serious harms such as intoxications, deaths (EMCDDA, 2016). NPS consumption also include broader social harms that still requiring attention and further research.

Nightlife settings are ‘therefore relevant to developing an understanding and response to NPS use and provide opportunities to target recreational and harmful drug use’ Interviews and observation - the experiences of NPS from nightlife key-agents: the party workers Despite the overall use of NPS in nightlife settings is relatively low compared to traditional club drugs (Stephenson and Richardson, 2014), the use of drugs and alcohol has been associated with an increased risk of a range of health and social harms such as injury, aggressive behaviour, unsafe / unwanted sex and driving under the influence (Charlois, 2009). This work is part of a research work in progress in the scope of a PhD in Sociology and builds on an earlier study conducted on NPS users prior to legislative controls (Silva, 2012).

Sex Age School Job Drug use / NPS Female 28 University degree Party producer Dj Cannabis (daily basis), 2cb, MXE 30 Secondary school Unemployed, temporary jobs, organized some parties Cannabis (daily basis), 2cb, DMT Male 37 Dj, tourist guide Cannabis (daily basis) 23 Hotel manager, party worker

Research questions: In what night settings and contexts are the NPS used? Which NPS are being used in these nightlife settings? Where are these NPS sourced? What is the impact of online markets? What are the experiences of these NPS in terms of drug related outcome? What level of harm reduction awareness is there, and what harm reduction practices are used?  

In what night settings and contexts are the NPS used? Nightlife recreational contexts “Music lovers and party goers, no doubt.” “Party goers.”

Which NPS are being used in these nightlife settings? 2cb, MXE, DMT, Salvia, Nbomes, Changa, LSI, 25i… “NPS are the new drugs, so those drugs that nobody knows exactly what they are or what they do…” “Legal imitations of ilegal drugs.” “NPS are basically studies (…) you have designer drugs since the 80´s and now there are that ones from smartshops (…) resulting of studies and discoveries.” “NPS are things that people put out in the markets… are new substances”

Where are these NPS sourced? what is the impact of online markets? “… some people usually buy drugs in the parties, other ones bringing the stuff from other places (...) I don’t know where from.” “Probably there are some ‘home laboratories’ in Portugal…” “At the begining NPS were sold on the internet, then in the smartshops and more people had access to NSP.” “Only few people buy NPS on the internet…”

What are the experiences of these NPS in terms of drug related outcome? “The most frequent bad experiences are with hallucinogenic type of substances…” “There are some crises with MDMA or LSD.”

What level of harm reduction awareness is there, and what harm reduction practices are used? “Some information in international platforms and forums.” “We share experiences and advise the ones that are using for the first time…” “I was in a festival where there was a drug testing service, but that is not usual.”

In conclusion: No consensual NPS definition – focus on ‘new’ Low risk and harm attention Prevalence and patterns of polydrug uses Parallels and intersections between NPS and traditional drugs

New Psychoactive Substances in Portugal Trends and approaches jpaulapbrsilva@gmail.com Susana_alexandra_henriques@iscte.pt